Drug recall · November 1, 2017
Methylphenidate Hydrochloride Tablets USP recall
Why: Failed Dissolution Specifications: Low out of specification results for dissolution.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 0591-5884-01.
- Lots / codes
Lot Number # 1156086M, Exp 08/18
- Quantity
- 58,292 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- October 17, 2017 · Voluntary: Firm initiated
- Classified
- October 26, 2017
- Reported
- November 1, 2017
- Ended
- April 12, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylphenidate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.